Related Experiment Video
Updated: May 17, 2026

07:39
Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock
Published on: August 16, 2021
Percutaneous left ventricular partitioning device for chronic heart failure.
K Boerlage-van Dijk1, P G Meregalli, R N Planken
1Department of Cardiology, Academic Medical Center - University of Amsterdam, Meibergdreef 9, 1105AZ, Amsterdam, the Netherlands.
Summary
The Netherlands saw its first percutaneous left ventricular partitioning device implantation. This innovative treatment is for chronic heart failure patients with left ventricular apical aneurysms from anterior myocardial infarction.
Area of Science:
- Cardiology
- Medical Devices
- Heart Failure Management
Background:
- Chronic heart failure is a significant burden, often resulting from myocardial infarction.
- Left ventricular apical aneurysms are a complication of anterior myocardial infarction, leading to reduced cardiac function.
- Current treatment options for this specific condition may be limited.
Purpose of the Study:
- To report the initial clinical experience with a novel percutaneous left ventricular partitioning device.
- To evaluate the feasibility and implications of this new therapeutic approach in the Netherlands.
- To address the unmet need in managing heart failure secondary to left ventricular apical aneurysms.
Main Methods:
- Percutaneous implantation of a left ventricular partitioning device.
- Procedure performed in a patient with chronic heart failure and a left ventricular apical aneurysm.
- Device designed to partition the left ventricle and improve hemodynamics.
Main Results:
- Successful first-in-Netherlands implantation of the percutaneous left ventricular partitioning device.
- The procedure was technically feasible in the reported case.
- The device aims to address the pathophysiology of heart failure in this patient cohort.
Conclusions:
- The percutaneous left ventricular partitioning device represents a new therapeutic option for specific heart failure patients.
- This initial report highlights the potential of minimally invasive strategies for complex cardiac conditions.
- Further research and larger studies are warranted to establish the long-term efficacy and safety of this device.
Related Concept Videos
Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
